11/12
01:23 pm
tcrt
Alaunos Therapeutics (NASDAQ:TCRT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Alaunos Therapeutics (NASDAQ:TCRT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/7
01:12 am
tcrt
Alaunos Therapeutics (NASDAQ:TCRT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Alaunos Therapeutics (NASDAQ:TCRT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.